CytoTools AG (DE000A0KFRJ1/T5O) is a German biotechnology company that develops highly effective therapeutics from research on the regulation of programmed cell death. Based on many years of basic research CytoTools has built a solid pipeline of patent protected product candidates in the fields of dermatology, urology, cardiology and oncology. The most advanced and the main product, DermaPro®, is a fast and effective treatment of wounds of all kinds, which enables the closure of wounds that are difficult to heal such as the diabetic foot. The management team of CytoTools has many years of experience in research, the pharmaceutical industry and finance.
Huge market potential of the products
Highly qualified management team
Solid shareholder structure
Company short portrait
Here you find a short portrait in German.